NO742321L - - Google Patents
Info
- Publication number
- NO742321L NO742321L NO742321A NO742321A NO742321L NO 742321 L NO742321 L NO 742321L NO 742321 A NO742321 A NO 742321A NO 742321 A NO742321 A NO 742321A NO 742321 L NO742321 L NO 742321L
- Authority
- NO
- Norway
- Prior art keywords
- ferric
- acid
- test strip
- salt
- phenylketone
- Prior art date
Links
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 14
- 239000002250 absorbent Substances 0.000 claims description 11
- 230000002745 absorbent Effects 0.000 claims description 11
- 239000000797 iron chelating agent Substances 0.000 claims description 11
- 229940075525 iron chelating agent Drugs 0.000 claims description 11
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 10
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- -1 alkali metal salts Chemical class 0.000 claims description 6
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 claims description 6
- FPFSGDXIBUDDKZ-UHFFFAOYSA-N 3-decyl-2-hydroxycyclopent-2-en-1-one Chemical compound CCCCCCCCCCC1=C(O)C(=O)CC1 FPFSGDXIBUDDKZ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 claims description 4
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 4
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 claims description 4
- 229910000360 iron(III) sulfate Inorganic materials 0.000 claims description 4
- 239000005955 Ferric phosphate Substances 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- VEPSWGHMGZQCIN-UHFFFAOYSA-H ferric oxalate Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O VEPSWGHMGZQCIN-UHFFFAOYSA-H 0.000 claims description 3
- 229940032958 ferric phosphate Drugs 0.000 claims description 3
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 claims description 3
- 229910000399 iron(III) phosphate Inorganic materials 0.000 claims description 3
- SHXXPRJOPFJRHA-UHFFFAOYSA-K iron(iii) fluoride Chemical compound F[Fe](F)F SHXXPRJOPFJRHA-UHFFFAOYSA-K 0.000 claims description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 3
- 229960003330 pentetic acid Drugs 0.000 claims description 3
- FEONEKOZSGPOFN-UHFFFAOYSA-K tribromoiron Chemical compound Br[Fe](Br)Br FEONEKOZSGPOFN-UHFFFAOYSA-K 0.000 claims description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
- 229960001484 edetic acid Drugs 0.000 claims 2
- 229960002413 ferric citrate Drugs 0.000 claims 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims 2
- 229940123150 Chelating agent Drugs 0.000 claims 1
- 201000011252 Phenylketonuria Diseases 0.000 description 14
- 210000002700 urine Anatomy 0.000 description 13
- 229920002678 cellulose Polymers 0.000 description 10
- 239000001913 cellulose Substances 0.000 description 10
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 5
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 5
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 229910001447 ferric ion Inorganic materials 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000036364 Normal newborn Diseases 0.000 description 1
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000736772 Uria Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229960004887 ferric hydroxide Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48105291A JPS5240239B2 (ja) | 1973-09-18 | 1973-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO742321L true NO742321L (ja) | 1975-04-14 |
Family
ID=14403566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO742321A NO742321L (ja) | 1973-09-18 | 1974-06-26 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3954412A (ja) |
| JP (1) | JPS5240239B2 (ja) |
| BE (1) | BE816924A (ja) |
| CA (1) | CA1021235A (ja) |
| CH (1) | CH598595A5 (ja) |
| DE (1) | DE2432752A1 (ja) |
| DK (1) | DK332274A (ja) |
| ES (1) | ES427746A1 (ja) |
| FR (1) | FR2244174B1 (ja) |
| GB (1) | GB1444294A (ja) |
| IT (1) | IT1016643B (ja) |
| NL (1) | NL7410508A (ja) |
| NO (1) | NO742321L (ja) |
| SE (1) | SE7408130L (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2385377A2 (fr) * | 1976-04-29 | 1978-10-27 | Inst Nat Rech Securite | Procede de fixation des metabolites urinaires sur un support adsorbant et dispositif pour la mise en oeuvre de ce procede |
| JPS55142249A (en) * | 1979-04-24 | 1980-11-06 | Shionogi & Co Ltd | Reduction type ascorbic acid detecting composition and test piece |
| US4288541A (en) * | 1979-10-15 | 1981-09-08 | Miles Laboratories, Inc. | Ascorbate resistant composition, test device and method for detecting a component in a liquid test sample |
| US4472507A (en) * | 1981-06-04 | 1984-09-18 | Pluim Jr Arthur W | Method for detecting exposure to poison ivy and the like |
| US5362630A (en) * | 1981-07-28 | 1994-11-08 | Duke University | Isolation of pseudomonas salicylate hydroxlase and its use for the identification and quantitation of salicylate in body fluids |
| US4397956A (en) * | 1981-12-10 | 1983-08-09 | Maggio Edward T | Means for monitoring the status of control of ketoacidosis-prone diabetics |
| US4701420A (en) * | 1985-04-01 | 1987-10-20 | Eastman Kodak Company | Analytical compositions, elements and methods utilizing reduction of ferric ion chelates to form detectable dyes |
| JPH03290443A (ja) * | 1990-04-06 | 1991-12-20 | Sakai Eng Kk | イオン交換能を持つ官能基を導入したセルロース連続発泡体形成物 |
| GB0405648D0 (en) * | 2004-03-12 | 2004-04-21 | Bloomsbury Innovations Ltd | Apparatus |
| US10330603B1 (en) * | 2016-04-08 | 2019-06-25 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents |
| US9759733B1 (en) * | 2016-04-08 | 2017-09-12 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of narcotics |
| WO2019050837A1 (en) * | 2017-09-06 | 2019-03-14 | Clemson University Research Foundation | COUPON DESIGN WITH ENHANCED COLOR SENSITIVITY FOR LIQUID-BASED CHEMICAL ANALYSIS OF LIQUIDS |
| CN110441524A (zh) * | 2019-07-22 | 2019-11-12 | 浙江大学 | 检测苯丙酮尿症标记物的抗体在制备诊断试纸中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT609831A (ja) * | 1958-06-16 | |||
| GB1050880A (ja) * | 1964-11-13 | |||
| US3537906A (en) * | 1966-01-05 | 1970-11-03 | Allis Chalmers Mfg Co | Process for producing a fuel cell electrode |
| US3511611A (en) * | 1968-01-23 | 1970-05-12 | Pfizer & Co C | Blood urea nitrogen test |
-
1973
- 1973-09-18 JP JP48105291A patent/JPS5240239B2/ja not_active Expired
-
1974
- 1974-06-17 US US05/480,308 patent/US3954412A/en not_active Expired - Lifetime
- 1974-06-19 SE SE7408130A patent/SE7408130L/xx unknown
- 1974-06-20 DK DK332274A patent/DK332274A/da unknown
- 1974-06-25 CA CA203,372A patent/CA1021235A/en not_active Expired
- 1974-06-26 BE BE145944A patent/BE816924A/xx unknown
- 1974-06-26 NO NO742321A patent/NO742321L/no unknown
- 1974-06-27 ES ES427746A patent/ES427746A1/es not_active Expired
- 1974-06-28 FR FR7422699A patent/FR2244174B1/fr not_active Expired
- 1974-07-08 DE DE2432752A patent/DE2432752A1/de not_active Withdrawn
- 1974-07-10 GB GB3058374A patent/GB1444294A/en not_active Expired
- 1974-07-19 IT IT69309/74A patent/IT1016643B/it active
- 1974-07-19 CH CH1000474A patent/CH598595A5/xx not_active IP Right Cessation
- 1974-08-05 NL NL7410508A patent/NL7410508A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1444294A (en) | 1976-07-28 |
| CH598595A5 (ja) | 1978-05-12 |
| JPS5057300A (ja) | 1975-05-19 |
| IT1016643B (it) | 1977-06-20 |
| SE7408130L (ja) | 1975-03-19 |
| DE2432752A1 (de) | 1975-04-03 |
| AU7053274A (en) | 1976-01-08 |
| FR2244174B1 (ja) | 1978-01-27 |
| US3954412A (en) | 1976-05-04 |
| NL7410508A (nl) | 1975-03-20 |
| FR2244174A1 (ja) | 1975-04-11 |
| DK332274A (ja) | 1975-06-02 |
| ES427746A1 (es) | 1977-02-01 |
| CA1021235A (en) | 1977-11-22 |
| BE816924A (fr) | 1974-10-16 |
| JPS5240239B2 (ja) | 1977-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3406015A (en) | Means for detecting the fertile period | |
| Schloss | Colorimetric determination of glucosamine | |
| NO742321L (ja) | ||
| Junqueira et al. | A simple and sensitive method for the quantitative estimation of collagen | |
| US4147514A (en) | Test means and method for detecting ketone bodies | |
| Starcher | Determination of the elastin content of tissues by measuring desmosine and isodesmosine | |
| SU633501A3 (ru) | Реагент дл обнаружени белка в моче | |
| JPS6412343B2 (ja) | ||
| US2990253A (en) | Diagnostic composition | |
| US5397710A (en) | Process for measuring magnesium in biological fluids | |
| US3880590A (en) | Test strip for ketone bodies | |
| EP0098562A1 (de) | Verfahren zur Bestimmung von direktem und Gesamt-Bilirubin sowie hierfür geeignetes Reagens | |
| NO742322L (ja) | ||
| DE2432754A1 (de) | Teststreifen zum nachweis von bilirubin | |
| US4132527A (en) | Diagnostic compositions, diagnosing instruments, and methods of manufacturing same | |
| US3406016A (en) | Means for detecting the fertile period | |
| Nagashima et al. | Spectrophotometric determination of cyanide with isonicotinic acid and barbituric acid | |
| US4184850A (en) | Diagnostic agent for the detection of ketone bodies in fluids and process for its manufacture | |
| US3971702A (en) | Diagnostic composition for saccharide determination | |
| JPH0564745B2 (ja) | ||
| US3415717A (en) | Bacteriuria test papers | |
| US5106753A (en) | Method for determining manganese level in blood using a porphyrin composition | |
| Barash et al. | Improved 63Ni radiochemical assay of free fatty acids in plasma. | |
| Buyske et al. | The stability of Coenzyme A1 | |
| US3048475A (en) | Method and diagnostic composition of detecting phenylketones |